Cargando…
FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas
PET using (18)F-FDG for treatment monitoring in patients with lymphoma is one of the most well-developed clinical applications. PET/CT is nowadays used during treatment to assess chemosensitivity, with response-adapted therapy given according to ‘interim’ PET in clinical practice to adults and child...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5541086/ https://www.ncbi.nlm.nih.gov/pubmed/28411336 http://dx.doi.org/10.1007/s00259-017-3690-8 |